serena williams before and after glp 1 reveals she's been taking a GLP-1 medication to help her with weight loss, she's down 31 pounds. She's launching a campaign with the health care company Ro to normalize Serena Williams' Inspiring Weight Loss

However, phase I and II clinical trial results have shown that although retatrutide has promising results for weight loss, it may have a few side effects to consider

Are GLP-1 patches side effects dangerous

Here are the results: Dose-dependent weight loss The phase 2 trial demonstrated a dose-dependent relationship between retatrutide and weight loss

Dr Khoo noted that these medications are costly and offer only short-term results

2026 TECHTIMES.com All rights reserved

Dual receptor agonism (GIP + GLP-1) Enhanced metabolic effects in comparative studies Weekly administration research protocols FDA-approved with growing clinical literature Retatrutide Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously